Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05446584 · ClinicalTrials.gov registry record · Phase 2

Pathways Relating Amnestic MCI to a Mild Traumatic Brain Injury History

A Phase 2 study of Mild Cognitive Impairment and Mild Traumatic Brain Injury, sponsored by University of Texas Southwestern Medical Center.

Recruiting
Registry status
Phase 2
Development phase
75
Enrollment target
1
Study location

NCT05446584 is a Phase 2 study of Mild Cognitive Impairment and Mild Traumatic Brain Injury that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 75 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05446584, a Phase 2 study of Mild Cognitive Impairment and Mild Traumatic Brain Injury, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.

RECRUITING
Registry status
Phase 2
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

This study will probe if the biological changes in amnestic mild cognitive impairment (aMCI) are related to a history of mild traumatic brain injury (mTBI) using high definition transcranial direct current stimulation (HD-tDCS) and blood-derived biomarker tools. Participants who Do as well as those who Do Not have a history of mTBI will be enrolled in the study.

Conditions Studied

Mild Cognitive Impairment Mild Traumatic Brain Injury Concussion, Brain Amnestic Mild Cognitive Disorder Amnestic Mild Cognitive Impairment

Interventions

  • DEVICE High Definition Transcranial Direct Current Stimulation

Study Locations (1)

Texas

  • University of Texas Southwestern Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2023-04-20
Est. Completion 2027-05-31
Phase Phase 2

Sponsor

University of Texas Southwestern Medical Center

837 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05446584

The ClinicalTrials.gov registry entry for NCT05446584 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (94% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 1 intervention - of which High Definition Transcranial Direct Current Stimulation is the first listed.

NCT05446584 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05446584 about?

NCT05446584 is a clinical study titled "Pathways Relating Amnestic MCI to a Mild Traumatic Brain Injury History". This study will probe if the biological changes in amnestic mild cognitive impairment (aMCI) are related to a history of mild traumatic brain injury (mTBI) using high definition transcranial direct current stimulation (HD-tDCS) and blood-derived biomarker tools. Participants who Do as well as those ...

What is the current status of trial NCT05446584?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 75 participants. The study started on 2023-04-20. Estimated completion is 2027-05-31.

What conditions does trial NCT05446584 study?

This clinical trial studies the following conditions: Mild Cognitive Impairment, Mild Traumatic Brain Injury, Concussion, Brain, Amnestic Mild Cognitive Disorder, Amnestic Mild Cognitive Impairment.

What interventions are being tested in trial NCT05446584?

The interventions under investigation include: High Definition Transcranial Direct Current Stimulation (DEVICE).

Who is sponsoring clinical trial NCT05446584?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05446584 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Mild Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Mild Cognitive Impairment

All registered trials for this condition

Mild Traumatic Brain Injury

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.